Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity.
Eur J Med Chem
; 192: 112186, 2020 Apr 15.
Article
in En
| MEDLINE
| ID: mdl-32145645
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sulfonamides
/
Blood Platelets
/
Bcl-X Protein
/
Drug Discovery
/
Proteolysis
/
Aniline Compounds
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Eur J Med Chem
Year:
2020
Document type:
Article